Sotrovimab, sold under the brand name Xevudy, is a human neutralizing monoclonal antibody with activity against severe acute respiratory syndrome coronavirus...

was approved for medical use in the European Union in November 2021. Sotrovimab, sold under the brand name Xevudy, is a human neutralizing monoclonal...

neutralization tests indicate monoclonal antibody therapies (with the exception of sotrovimab and tixagevimab/cilgavimab) were not likely to be active against the Omicron...

severe or critical patients. It also recommended the monoclonal antibody Sotrovimab in patients with non-severe disease, but only those who are at highest...

Bamlanivimab Etesevimab Bebtelovimab Casirivimab/imdevimab Regdanvimab Sarilumab Sotrovimab Tixagevimab/cilgavimab Tocilizumab Small molecule antivirals Broad-spectrum...

Motavizumab J06BD03 Tixagevimab and cilgavimab J06BD04 Ansuvimab J06BD05 Sotrovimab J06BD06 Regdanvimab J06BD07 Casirivimab and imdevimab J06BD08 Nirsevimab...

of antigenic sites outside the RBM, including sotrovimab (VIR-7831), S2X259 and S2H97. However, sotrovimab was not fully active against the BA.2 Omicron...

192–198. doi:10.1002/jcp.21588. PMC 2905312. PMID 18781584. "AusPAR: Sotrovimab". Therapeutic Goods Administration (TGA). 20 August 2021. Archived from...

imdevimab appear to still be effective. A preprint study suggests that sotrovimab may also be effective against Delta. Doctors in Singapore have been using...

the United States: bamlanivimab/etesevimab, casirivimab/imdevimab, and sotrovimab. Bamlanivimab/etesevimab was not recommended in the United States due...